Personalized Medicine – Products

The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.

Recent data released by Autoscribe Informatics shows the breadth of industries purchasing a Laboratory Information Management System (LIMS); many for the first time.

A genetic test alone may not be able to provide the information needed for a final diagnosis. With a complete clinical picture via multiomics data, the process and precision of treating rare, metabolic, and neurodegenerative diseases is being redefined.

Sino Biological, Inc. is pleased to announce the formal signing of a lease with Hines and initiation of construction on its new Center for Bioprocessing (C4B) at its Levit Green facility in Houston, Texas USA.

OncoHost has developed a novel predictive model for clinical benefit of immune checkpoint inhibitor in non-small cell lung cancer patients.

The MACSima™ Imaging Platform opens the next level of context in spatial biology, allowing fully automated imaging of 100s of protein markers on a single tissue sample. It includes a broad portfolio of pre-validated antibodies and an easy-to-use software generating ready-to-publish images and charts.

The SQUEEZE project planned to start early 2023 will discover new ways to maximize the impact of prescription drugs for patients suffering from the chronic autoimmune disease Rheumatoid Arthritis.

Medix Biochemica has announced the appointment of Dr. Michele Pedrocchi to their Board of Directors.

To meet the need for rapid genomic insights, Thermo Fisher Scientific has launched the CE-IVD (IVDD) Oncomine Dx Express Test and Oncomine Reporter Dx for use in clinical labs.

Paradigm4 has launched the Precision Cell Atlas as an integral component of its REVEAL: SingleCell app.